{"id":"tramadol-hcl-twice-a-day","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"10-20%","effect":"Dizziness"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Somnolence"},{"rate":"5-10%","effect":"Constipation"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Tramadol HCl is a weak mu-opioid receptor agonist and a norepinephrine reuptake inhibitor. It also inhibits the reuptake of serotonin, which contributes to its analgesic effects. By binding to opioid receptors, tramadol HCl reduces the transmission of pain signals to the brain, providing pain relief.","oneSentence":"Tramadol HCl is a centrally acting opioid analgesic that works by binding to opioid receptors in the brain and spinal cord, reducing pain perception.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:39:43.230Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Moderate to moderately severe pain"},{"name":"Severe pain"}]},"trialDetails":[{"nctId":"NCT05488847","phase":"PHASE4","title":"Opioid-Free Pain Protocol After Shoulder Arthroplasty","status":"ACTIVE_NOT_RECRUITING","sponsor":"Henry Ford Health System","startDate":"2022-06-25","conditions":"Shoulder Arthropathy, Shoulder Pain","enrollment":83},{"nctId":"NCT05311774","phase":"NA","title":"Efficacy of Duloxetine in Conjunction With Tramadol for Chronic Cancer Pain","status":"COMPLETED","sponsor":"Assiut University","startDate":"2022-04-01","conditions":"Cancer Pain","enrollment":400},{"nctId":"NCT05125978","phase":"PHASE2","title":"Efficacy and Safety of Canadá Association in the Treatment of Chronic Pain","status":"WITHDRAWN","sponsor":"EMS","startDate":"2026-09","conditions":"Pain, Chronic","enrollment":""},{"nctId":"NCT04766996","phase":"PHASE4","title":"PROUD Study - Preventing Opioid Use Disorders","status":"TERMINATED","sponsor":"Emory University","startDate":"2021-05-17","conditions":"Anesthesia, Opioid Use","enrollment":57},{"nctId":"NCT00662558","phase":"PHASE3","title":"A Six Week Study Of The Pain Relieving Effects Of Celecoxib 200 Mg Twice Daily Compared To Tramadol 50 Mg Four Times Daily In Patients With Chronic Low Back Pain","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2008-01","conditions":"Low Back Pain","enrollment":802},{"nctId":"NCT04589494","phase":"PHASE2, PHASE3","title":"Effect of Tramadol Versus Morphine on PD1 and PD1-ligand in Patients With Chronic Cancer Pain","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2020-04-16","conditions":"Chronic Pain","enrollment":15},{"nctId":"NCT02198924","phase":"PHASE4","title":"Efficacy and Safety of Postoperative Intravenous Parecoxib Sodium Followed by Oral Celecoxib in Osteoarthritis Patients","status":"COMPLETED","sponsor":"Peking Union Medical College Hospital","startDate":"2014-12","conditions":"Pain, Inflammation","enrollment":246},{"nctId":"NCT03126084","phase":"PHASE4","title":"Postoperative Effects of TAP Block Versus QLB Type 2 Block","status":"COMPLETED","sponsor":"Bozyaka Training and Research Hospital","startDate":"2017-05-02","conditions":"Inguinal Hernia, Postoperative Pain","enrollment":90},{"nctId":"NCT01983111","phase":"PHASE4","title":"Compare the Efficacy and Safety of Norspan to Tramadol/Acetaminophen With Prolonged Postoperative Pain (PASSION)","status":"COMPLETED","sponsor":"Mundipharma Korea Ltd","startDate":"2013-10","conditions":"Pain","enrollment":136},{"nctId":"NCT01819805","phase":"","title":"A Study to Assess the Improvement of Pain and Health-Related Quality of Life in Patients With Chronic Non-Malignant Pain Taking Tramadol Hydrochloride and Acetaminophen","status":"COMPLETED","sponsor":"Janssen Korea, Ltd., Korea","startDate":"2011-09","conditions":"Chronic Pain","enrollment":1065},{"nctId":"NCT00634543","phase":"PHASE4","title":"A Study to Compare Safety and Efficacy of Tramadol Hydrochloride/Acetaminophen With Gabapentin in Participants With Diabetic Neuropathy","status":"COMPLETED","sponsor":"Janssen Korea, Ltd., Korea","startDate":"2006-12","conditions":"Diabetic Neuropathy","enrollment":162},{"nctId":"NCT01112267","phase":"PHASE3","title":"An Efficacy and Safety Study of Extended Release (ER) Tramadol Hydrochloride (HCl)/Acetaminophen in Participants With Chronic Low-Back Pain","status":"COMPLETED","sponsor":"Janssen Korea, Ltd., Korea","startDate":"2009-05","conditions":"Low Back Pain","enrollment":248},{"nctId":"NCT00635349","phase":"PHASE4","title":"A Comparative Study of Tramadol Hydrochloride Plus Acetaminophen Tablets Maintenance Versus Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Maintenance in Participants With Knee Osteoarthritis","status":"COMPLETED","sponsor":"Janssen Korea, Ltd., Korea","startDate":"2007-05","conditions":"Osteoarthritis","enrollment":143},{"nctId":"NCT00766675","phase":"PHASE4","title":"An Efficacy Study of Combination of Tramadol and Acetaminophen Tablets in the Treatment of Participants With Fibromyalgia Pain","status":"COMPLETED","sponsor":"Johnson & Johnson Taiwan Ltd","startDate":"2008-10","conditions":"Pain, Fibromyalgia","enrollment":80},{"nctId":"NCT01116531","phase":"PHASE4","title":"Efficacy, Safety, Tolerability and Pharmacokinetics of Concomitant Administration of Tramadol With Duloxetine or Pregabalin","status":"WITHDRAWN","sponsor":"Turku University Hospital","startDate":"2010-04","conditions":"Diabetic Polyneuropathy, Postherpetic Neuralgia","enrollment":""},{"nctId":"NCT01443520","phase":"PHASE4","title":"Effect of Duloxetine and Venlafaxine on the Pharmacokinetics and Pharmacodynamics of Oral Tramadol: A Three-phase Randomized Balanced Cross-over Study in Healthy Volunteers","status":"COMPLETED","sponsor":"Turku University Hospital","startDate":"2011-10","conditions":"Healthy","enrollment":12},{"nctId":"NCT00950651","phase":"PHASE3","title":"A Comparison of the Analgesic Efficacy and Safety of Once Daily Tramadol HCl / Contramid® Tablets to Twice Daily Tramadol HCl (SR) for the Treatment of Osteoarthritis of the Knee","status":"COMPLETED","sponsor":"Labopharm Inc.","startDate":"2002-03","conditions":"Osteoarthritis, Knee, Pain","enrollment":431},{"nctId":"NCT00973232","phase":"PHASE1","title":"A Comparative Bioavailability/Food Effect Study of Immediate-Release and Extended-Release Tramadol HCl/Acetaminophen Combination Products Following Single-Dose and Multiple-Dose Administration in Healthy Adult Volunteers","status":"COMPLETED","sponsor":"Labopharm Inc.","startDate":"2008-05","conditions":"Healthy","enrollment":58}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":25,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Tramadol HCl Twice a day","genericName":"Tramadol HCl Twice a day","companyName":"Labopharm Inc.","companyId":"labopharm-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Tramadol HCl is a centrally acting opioid analgesic that works by binding to opioid receptors in the brain and spinal cord, reducing pain perception. Used for Moderate to moderately severe pain, Severe pain.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}